textabstractCIITA activates the expression of multiple genes involved in antigen presentation and it is believed to be required for both constitutive and IFNγ-inducible expression of these genes. To understand the role of CIITA in vivo, we have used gene targeting to generate mice that lack CIITA. CIITA-deficient (-/-) mice do not express conventional MHC class II molecules on the surface of splenic B cells and dendritic cells. In addition, macrophages resident in the peritoneal cavity do not express MHC class II molecules upon IFNγ stimulation nor do somatic tissues of mice injected with IFNγ, in contrast with wild-type mice. The levels of li and H-2M gene transcripts are substantially decreased but not absent in CIITA (-/-) mice. The tran...
AbstractClass II transactivator (CIITA) is known as a coactivator for MHC class II gene expression i...
The MHC class II transactivator (CIITA) is the master transcriptional regulator of genes involved in...
We previously demonstrated the generation of a CD4 T cell-specific long lasting anti-tumor immune re...
AbstractCIITA activates the expression of multiple genes involved in antigen presentation and it is ...
CIITA is a master regulatory factor for the expression of MHC class II (MHC-II) and accessory genes ...
CIITA is a master regulatory factor for the expression of MHC class II (MHC-II) and accessory genes ...
AbstractPatients with major histocompatibility complex class II (MHC-II) deficiency are known to car...
Patients with major histocompatibility complex class II (MHC-II) deficiency are known to carry mutat...
The MHC Class II Transactivator, CIITA, is a master regulator of genes involved in antigen presentat...
Three distinct promoters control the master regulator of MHC class II expression, CIITA, in a cell t...
MHC class II (MHCII) molecules play a pivotal role in the induction and regulation of immune respons...
The MHC class II (MHC-II) transactivator (CIITA) is the master transcriptional regulator of genes in...
MHC class II (MHCII) deficiency of Bare Lymphocyte Syndrome (BLS) is a severe immunodeficiency chara...
The MHC class II (MHC-II) transactivator (CIITA) is the master transcriptional regulator of genes in...
Despite the fact that major histocompatibility complex class II transactivator (CIITA) has been know...
AbstractClass II transactivator (CIITA) is known as a coactivator for MHC class II gene expression i...
The MHC class II transactivator (CIITA) is the master transcriptional regulator of genes involved in...
We previously demonstrated the generation of a CD4 T cell-specific long lasting anti-tumor immune re...
AbstractCIITA activates the expression of multiple genes involved in antigen presentation and it is ...
CIITA is a master regulatory factor for the expression of MHC class II (MHC-II) and accessory genes ...
CIITA is a master regulatory factor for the expression of MHC class II (MHC-II) and accessory genes ...
AbstractPatients with major histocompatibility complex class II (MHC-II) deficiency are known to car...
Patients with major histocompatibility complex class II (MHC-II) deficiency are known to carry mutat...
The MHC Class II Transactivator, CIITA, is a master regulator of genes involved in antigen presentat...
Three distinct promoters control the master regulator of MHC class II expression, CIITA, in a cell t...
MHC class II (MHCII) molecules play a pivotal role in the induction and regulation of immune respons...
The MHC class II (MHC-II) transactivator (CIITA) is the master transcriptional regulator of genes in...
MHC class II (MHCII) deficiency of Bare Lymphocyte Syndrome (BLS) is a severe immunodeficiency chara...
The MHC class II (MHC-II) transactivator (CIITA) is the master transcriptional regulator of genes in...
Despite the fact that major histocompatibility complex class II transactivator (CIITA) has been know...
AbstractClass II transactivator (CIITA) is known as a coactivator for MHC class II gene expression i...
The MHC class II transactivator (CIITA) is the master transcriptional regulator of genes involved in...
We previously demonstrated the generation of a CD4 T cell-specific long lasting anti-tumor immune re...